Authors: Morrison, BW Fricke, J Brown, J Yuan, WY Kotey, P Mehlisch, D

Citation: Bw. Morrison et al., The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials, J AM DENT A, 131(12), 2000, pp. 1729-1737

Authors: Morrison, BW Christensen, S Yuan, WY Brown, J Amlani, S Seidenberg, B

Citation: Bw. Morrison et al., Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib inpost-dental surgery pain: A randomized, controlled trial, CLIN THER, 21(6), 1999, pp. 943-953

Authors: Morrison, BW Daniels, SE Kotey, P Cantu, N Seidenberg, B

Citation: Bw. Morrison et al., Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea:A randomized controlled trial, OBSTET GYN, 94(4), 1999, pp. 504-508

Authors: Catella-Lawson, F McAdam, B Morrison, BW Kapoor, S Kujubu, D Antes, L Lasseter, KC Quan, H Gertz, BJ Fitzgerald, GA

Citation: F. Catella-lawson et al., Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids, J PHARM EXP, 289(2), 1999, pp. 735-741

Authors: Cefai, D Morrison, BW Sckell, A Favre, L Balli, M Leunig, M Gimmi, CD

Citation: D. Cefai et al., Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer, INT J CANC, 83(3), 1999, pp. 393-400